-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, N98fUavzHONsBSzGJzABssQgSgLeurnrXhHVbuIkZ5gxIkmT9BC2rXvZri7kwpBQ laoWuxFCDLLMlGz9uPAAyg== 0000950137-00-001585.txt : 20000407 0000950137-00-001585.hdr.sgml : 20000407 ACCESSION NUMBER: 0000950137-00-001585 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19991231 FILED AS OF DATE: 20000406 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AKORN INC CENTRAL INDEX KEY: 0000003116 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 720717400 STATE OF INCORPORATION: LA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: SEC FILE NUMBER: 000-13976 FILM NUMBER: 594521 BUSINESS ADDRESS: STREET 1: 100 TRI STATE INTERNATIONAL STREET 2: SUITE 100 CITY: LINCOLNSHIRE STATE: IL ZIP: 60069 BUSINESS PHONE: 8472363800 MAIL ADDRESS: STREET 1: 100 TRI STATE INTERNATIONAL STREET 2: SUITE 100 CITY: LINCOLNSHIRE STATE: IL ZIP: 60069 10-K/A 1 FORM 10-K/A 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 - -------------------------------------------------------------------------------- FORM 10-K/A [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE YEAR ENDED DECEMBER 31, 1999 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 0-13976 AKORN, INC. (Name of registrant as specified in its charter) LOUISIANA 72-0717400 (State or other jurisdiction of (IRS Employer Identification No.) incorporation or organization) 2500 Millbrook Drive, Buffalo Grove, Illinois 60089 (Address of principal executive offices and zip code) Registrant's telephone number: (847) 279-6100 SECURITIES REGISTERED UNDER SECTION 12(b) OF THE EXCHANGE ACT: None SECURITIES REGISTERED UNDER SECTION 12(g) OF THE EXCHANGE ACT: Common Stock, No Par Value (Title of Class) Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X No ----- ----- Indicate by check mark if disclosure of delinquent filers in response to Item 405 of Regulation S-K is not contained in this form, and will not be contained, to the best of Registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [ ] The aggregate market value of the voting stock held by nonaffiliates (affiliates being, for these purposes only, directors, executive officers and holders of more than 5% of the Issuer's common stock) of the Issuer as of March 15, 2000 was approximately $124,200,000. The number of shares of the Issuer's common stock, no par value per share, outstanding as of March 15, 2000 was 18,968,802. DOCUMENTS INCORPORATED BY REFERENCE Part III of this Annual Report on Form 10-K incorporates by reference portions of the Registrant's definitive proxy statement for its 2000 Annual Meeting of Shareholders filed with the Securities and Exchange Commission on March 28, 2000. 2 Akorn, Inc. hereby amends Item 12, Part III of its Annual Report on Form 10-K for the fiscal year ended December 31, 1999 (which was incorporated by reference to the definitive proxy statement for its 2000 Annual Meeting of Shareholders filed on March 28, 2000) as follows: The information regarding Doyle S. Gaw and Directors and officers as a group (5 persons) in the table labeled "Beneficial Owners" shall be as set forth below: Beneficial Owner Shares Beneficially Owned Percent of Class - ---------------- ------------------------- ---------------- Doyle S. Gaw 105,360 (2) 0.52% Directors and officers as a group (5 persons) 5,707,824 (6) 28.39% 3 SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AKORN, INC. By: /s/ Floyd Benjamin -------------------------------- Floyd Benjamin Chief Executive Officer Date: April 6, 2000 Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant, and in the capacities and on the dates indicated.
Signature Title Date - --------- ----- ---- /s/ Floyd Benjamin Chief Executive Officer and Director April 6, 2000 - --------------------------- Floyd Benjamin (Principal Executive Officer) /s/ Rita J. McConville Chief Financial Officer April 6, 2000 - --------------------------- Rita J. McConville (Principal Financial Officer and Principal Accounting Officer) /s/ John N. Kapoor, Ph.D. Director April 6, 2000 - --------------------------- John N. Kapoor, Ph.D. /s/ Daniel E. Bruhl, M.D. Director April 6, 2000 - --------------------------- Daniel E. Bruhl, M.D. /s/ Doyle S. Gaw Director April 6, 2000 - --------------------------- Doyle S. Gaw
-----END PRIVACY-ENHANCED MESSAGE-----